# Safety Study of BMS-770767 in Subjects With Hypercholesterolemia

> **NCT01058083** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 81 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** BMS-770767
- **DRUG:** BMS-770767
- **DRUG:** BMS-770767
- **DRUG:** BMS-770767
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01058083
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2012-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01058083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01058083, "Safety Study of BMS-770767 in Subjects With Hypercholesterolemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01058083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*